The Impact of a State Medicaid Peer-Review Authorization Program on Pediatric Use of Antipsychotic Medications-Reference-Cited by-同舟云学术

The Impact of a State Medicaid Peer-Review Authorization Program on Pediatric Use of Antipsychotic Medications

Published:2018-03 Issue:3 Volume:69 Page:293-299
ISSN:1075-2730
Container-title:Psychiatric Services
language:en
Short-container-title:PS

Author:

Pennap Dinci¹,Burcu Mehmet¹,Safer Daniel J.¹,Zito Julie Magno¹

Affiliation:

1. Ms. Pennap, Dr. Burcu, and Dr. Zito are with the Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore. Dr. Zito is also with the Department of Psychiatry, University of Maryland, Baltimore. Dr. Safer is with the Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore.

Publisher

American Psychiatric Association Publishing

Subject

Psychiatry and Mental health

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in antipsychotic use among children and adolescents in Germany: a study using 2011–2020 nationwide outpatient claims data;Frontiers in Psychiatry;2023-12-12

2. Cost of Implementing an Evidence-Based Intervention to Support Safer Use of Antipsychotics in Youth;Administration and Policy in Mental Health and Mental Health Services Research;2023-06-01

3. Trends in Antipsychotic Medication Use in Young Privately Insured Children;Journal of the American Academy of Child & Adolescent Psychiatry;2021-07

4. Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and Commentary;Frontiers in Psychiatry;2021-06-14

5. Disorders Specific to Infants and Young Children;Child and Adolescent Behavioral Health;2021-02-05